caffeic acid phenethyl ester has been researched along with loxapine in 1 studies
| Studies (caffeic acid phenethyl ester) | Trials (caffeic acid phenethyl ester) | Recent Studies (post-2010) (caffeic acid phenethyl ester) | Studies (loxapine) | Trials (loxapine) | Recent Studies (post-2010) (loxapine) |
|---|---|---|---|---|---|
| 840 | 1 | 469 | 363 | 71 | 104 |
| Protein | Taxonomy | caffeic acid phenethyl ester (IC50) | loxapine (IC50) |
|---|---|---|---|
| 5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 1 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 5.5 | |
| D(2) dopamine receptor | Homo sapiens (human) | 0.054 | |
| Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.018 | |
| D(4) dopamine receptor | Homo sapiens (human) | 0.014 | |
| Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.018 | |
| Histamine H1 receptor | Rattus norvegicus (Norway rat) | 1 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.022 | |
| Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.018 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bennis, K; Ducki, S; Lesage, F; Vivier, D | 1 |
1 review(s) available for caffeic acid phenethyl ester and loxapine
| Article | Year |
|---|---|
Perspectives on the Two-Pore Domain Potassium Channel TREK-1 (TWIK-Related K(+) Channel 1). A Novel Therapeutic Target?
Topics: Arrhythmias, Cardiac; Depression; Epilepsy; Humans; Inflammation; Models, Molecular; Molecular Structure; Neuroprotective Agents; Pain; Potassium Channels, Tandem Pore Domain; Structure-Activity Relationship | 2016 |